He was the first recipient of the Psychiatrist of the Year from "Psychiatric Times", and the Fawcett Humanitarian Award of the NDMDA (now the Depression and Bipolar Support Alliance. Goodwin was one of only five psychiatrists on the "Current Contents" list of the most frequently cited scientists in the world and one of 12 listed in The Best Doctors in the U.S. Another focus of Goodwins' research was in SAD (seasonal affective disorder) where he enthusiastically endorsed the used of light therapy to assist with combating the debilitating effects of SAD a form of depression. Goodwin published 'Manic Depressive Illness' in 1990 with Kay Redfield Jamison, republished in 2007, which is considered a classic in the field. Goodwin hosted the award-winning radio show "The Infinite Mind." Started in 1997, the show (which at its height aired on over 300 public radio stations throughout the country), won more than 30 journalism awards over 10 years and was considered “public radio’s most honored and listened to health and science program." Since retiring from government, Goodwin has been actively involved in educating other psychiatrists through continuing medical education (CME) programs and pharmaceutical speakers' bureaus. The acknowledgements to Goodwin's 'Manic Depressive Illness' states that: "During the time that this book was in preparation, Dr. Goodwin received research support from George Washington University Medical Center, the Foundation for Education and Research on Mental Illness, the Dalio Family Foundation, GlaxoSmithKline, Pfizer, Eli Lilly, and Solvay. He has received honoraria from GlaxoSmithKline, Pfizer, Solvay, and Eli Lilly and unrestricted educational grants to support the production of this book from Abbott Laboratories, AstraZeneca, Bristol Meyers Squibb, Forest Laboratories, GlaxoSmithKline, Janssen, Eli Lilly, Pfizer, and Sanofi". An article in "The New York Times" (Nov. 21, 2008) said that Goodwin had hosted programs that recommended the use of drugs, without disclosing that he had received over a million dollars from their manufacturers. Goodwin was also on the board of directors of the Center for Medicine in the Public Interest, an "industry-funded front, or "Astroturf" group, which receives a majority of its funding from drug companies." and the radio show was also directly part-funded by pharmaceutical companies which was also not disclosed.